Training slides cover the basic pharmacokinetic properties of DAAs, review interactions between DAAs and antiretroviral medications and non-HIV medications, and how to modify treatment for HCV or HIV.
We are requesting input from prescribers on the supply of HIV care providers in the United States and its territories. Please complete this anonymous, one-time, 10-minute research survey. Your participation will help us understand the factors that influence the HIV care workforce. We need and value your perspective.